Tasneem F. Hasan

Tasneem F. Hasan

Auto-generated profile, based on publicly available information

Tasneem F. Hasan

Department of Neurology, Ochsner Louisiana State University Health Sciences Center, Shreveport, LA, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
RTRabih G. Tawk
Rabih G. Tawk
THTasneem F. Hasan
Tasneem F. Hasan
CDCaitlin E. D’sOuza
Caitlin E. D’sOuza
JPJeffrey B. Peel
Jeffrey B. Peel
WFWilliam D. Freeman
William D. Freeman

15 October 2018 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
AFA. M. Feyissa
A. M. Feyissa
THT. F. Hasan
T. F. Hasan
JMJ. F. Meschia
J. F. Meschia

1 June 2020 in Best Practice & Research Clinical Anaesthesiology
Verified
Journal Article
Closed access
THTasneem F. Hasan
Tasneem F. Hasan
RKRoger Everett Kelley
Roger Everett Kelley
Elyse M. CornettElyse M. Cornett
Elyse M. Cornett
RURichard D. Urman
Richard D. Urman
Alan David KayeAlan David Kaye
Alan David Kaye

1 June 2020 in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Verified
Journal Article
Open access
CCChristina I. Collins
Christina I. Collins
THTasneem F. Hasan
Tasneem F. Hasan
LMLesia H. Mooney
Lesia H. Mooney
JTJessica L. Talbot
Jessica L. Talbot
AFAmanda L. Fouraker
Amanda L. Fouraker
WFWilliam D. Freeman
William D. Freeman
To determine whether earlier hospital discharge is feasible and safe in selected patients with subarachnoid hemorrhage (SAH) using an outpatient "fast-track" protocol. We conducted a prospective quality improvement cohort study with the primary feasibility end point of patients with SAH deemed safe for discharge by treating team consensus. All patients received detailed education and outpatient transcranial Doppler monitoring; caregivers could contact the on-call team 24-7. Primary safety end points were adverse events after discharge and hospital readmission. From January 1, 2010, to January 1, 2015, our center had 377 SAH diagnoses, of which 200 were included in the final cohort, 36 qualifying for fast-track early discharge. The 30-day readmission rate for fast-track patients was 11.0% (4 of 36) compared with 11.4% (18 of 164) for non-fast-track patients. The rate of delayed cerebral ischemia and stroke was 3% (1 of 36) in the fast-track group vs 25.0% (41 of 164) for the non-fast-track group. Adverse events occurred in 11.0% (4 of 36) of the fast-track group compared with 26.0% (43 of 164) in the non-fast-track group. The mean length of stay was reduced 60% from 15 days to 6.6 days in the fast-track group. Although our fast-track group was relatively small, data suggested early feasibility and safety in a carefully selected group of patients with SAH. Direct and indirect financial benefits of early discharge over a 5-year period were an estimated savings at least $864,000 in overall costs. A comparative effectiveness study is planned to replicate and validate these results using a larger multicenter design.

1 January 2021 in Epilepsy & Behavior Reports
Verified
Journal Article
Open access
THTasneem F. Hasan
Tasneem F. Hasan
WTWilliam O. Tatum
William O. Tatum
• Routine EEG can define epilepsy, classify epilepsy syndromes, and aid in the initiation/withdrawal of ASM. • Performing serial routine EEGs increases the yield of interictal discharges. • Repeat routine EEG may be utilized as an alternative to continuous EEG in critically ill adults at hospitals with limited resources. • Despite COVID-19, EEG services continue, and the value of routine EEG is unchanged.

1 September 2018 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
THTasneem F. Hasan
Tasneem F. Hasan
WDWalter Duarte
Walter Duarte
OAOluwaseun O. Akinduro
Oluwaseun O. Akinduro
EGEric Goldstein
Eric Goldstein
RHRebecca Hurst
Rebecca Hurst
WFWilliam D. Freeman
William D. Freeman